148 related articles for article (PubMed ID: 18445659)
1. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
Oguri T; Ozasa H; Uemura T; Bessho Y; Miyazaki M; Maeno K; Maeda H; Sato S; Ueda R
Mol Cancer Ther; 2008 May; 7(5):1150-5. PubMed ID: 18445659
[TBL] [Abstract][Full Text] [Related]
2. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
[TBL] [Abstract][Full Text] [Related]
3. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS
Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.
Meng X; Wang G; Liu P; Hou J; Jin Y; Yu Y; Bai J; Chen F; Sun W; Fu S
Respirology; 2011 Nov; 16(8):1228-34. PubMed ID: 21883677
[TBL] [Abstract][Full Text] [Related]
5. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
Kathawala RJ; Wei L; Anreddy N; Chen K; Patel A; Alqahtani S; Zhang YK; Wang YJ; Sodani K; Kaddoumi A; Ashby CR; Chen ZS
Oncotarget; 2015 Jan; 6(1):510-21. PubMed ID: 25402202
[TBL] [Abstract][Full Text] [Related]
6. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
Shen T; Kuang YH; Ashby CR; Lei Y; Chen A; Zhou Y; Chen X; Tiwari AK; Hopper-Borge E; Ouyang J; Chen ZS
PLoS One; 2009 Oct; 4(10):e7520. PubMed ID: 19841739
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort.
Sone K; Oguri T; Uemura T; Takeuchi A; Fukuda S; Takakuwa O; Maeno K; Fukumitsu K; Kanemitsu Y; Ohkubo H; Takemura M; Ito Y; Niimi A
BMC Cancer; 2019 Mar; 19(1):246. PubMed ID: 30890141
[TBL] [Abstract][Full Text] [Related]
8. The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity.
Oguri T; Achiwa H; Sato S; Bessho Y; Takano Y; Miyazaki M; Muramatsu H; Maeda H; Niimi T; Ueda R
Mol Cancer Ther; 2006 Jul; 5(7):1800-6. PubMed ID: 16891466
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.
Hopper-Borge EA; Churchill T; Paulose C; Nicolas E; Jacobs JD; Ngo O; Kuang Y; Grinberg A; Westphal H; Chen ZS; Klein-Szanto AJ; Belinsky MG; Kruh GD
Cancer Res; 2011 May; 71(10):3649-57. PubMed ID: 21576088
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in the ATP-binding cassette transporter ABCC10 are associated with neutropenia in Japanese patients with lung cancer treated with nanoparticle albumin-bound paclitaxel.
Horiuchi M; Uemura T; Oguri T; Toda S; Yamamoto S; Suzuki Y; Kagawa Y; Sone K; Fukuda S; Mori Y; Fukumitsu K; Kanemitsu Y; Tajiri T; Ohkubo H; Takemura M; Ito Y; Maeno K; Niimi A
Invest New Drugs; 2022 Oct; 40(5):934-943. PubMed ID: 35759133
[TBL] [Abstract][Full Text] [Related]
11. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression.
Yeh JJ; Hsu WH; Wang JJ; Ho ST; Kao A
Respiration; 2003; 70(1):32-5. PubMed ID: 12584388
[TBL] [Abstract][Full Text] [Related]
12. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS
PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321
[TBL] [Abstract][Full Text] [Related]
13. Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).
Deng W; Dai CL; Chen JJ; Kathawala RJ; Sun YL; Chen HF; Fu LW; Chen ZS
Oncol Rep; 2013 Jun; 29(6):2479-85. PubMed ID: 23525656
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.
Shimomura M; Yaoi T; Itoh K; Kato D; Terauchi K; Shimada J; Fushiki S
Int J Oncol; 2012 Apr; 40(4):995-1004. PubMed ID: 22179563
[TBL] [Abstract][Full Text] [Related]
15. The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond.
Chen DQ; Xie Y; Cao LQ; Fleishman JS; Chen Y; Wu T; Yang DH
Drug Resist Updat; 2024 Mar; 73():101062. PubMed ID: 38330827
[TBL] [Abstract][Full Text] [Related]
16. Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.
Kathawala RJ; Sodani K; Chen K; Patel A; Abuznait AH; Anreddy N; Sun YL; Kaddoumi A; Ashby CR; Chen ZS
Mol Cancer Ther; 2014 Mar; 13(3):714-23. PubMed ID: 24431074
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line.
Chu JJ; Chiang CD; Rao CS; Chang WM; Lai YK
Anticancer Res; 2000; 20(4):2449-56. PubMed ID: 10953309
[TBL] [Abstract][Full Text] [Related]
18. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
Pesic M; Markovic JZ; Jankovic D; Kanazir S; Markovic ID; Rakic L; Ruzdijic S
J Chemother; 2006 Feb; 18(1):66-73. PubMed ID: 16572896
[TBL] [Abstract][Full Text] [Related]
19. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins.
Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q
Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.
Hopper-Borge E; Chen ZS; Shchaveleva I; Belinsky MG; Kruh GD
Cancer Res; 2004 Jul; 64(14):4927-30. PubMed ID: 15256465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
